Molecular Tumour Board (MTB): From Standard Therapy to Precision Medicine

Background: In the metastatic setting, cancer patients may not benefit from standard care regimes and their diseases undergo drug resistance due to tumour cell heterogeneity and genomic landscape complexity. In recent years, there have been several attempts to personalise the diagnostic-therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Ballatore, Zelmira, Bozzi, Francesco, Cardea, Sara, Savino, Francesco Domenico, Migliore, Antonella, Tarantino, Valentina, Chiodi, Natalia, Ambrosini, Elisa, Bianchi, Francesca, Goteri, Gaia, Filosa, Alessandra, Barbisan, Francesca, Bartoli, Elisa, Papa, Roberto, Berardi, Rossana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607087/
https://www.ncbi.nlm.nih.gov/pubmed/37892804
http://dx.doi.org/10.3390/jcm12206666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607087/
https://www.ncbi.nlm.nih.gov/pubmed/37892804
http://dx.doi.org/10.3390/jcm12206666

Ejemplares similares